Precision Health Media offers audience targeting for pharmaceutical and consumer advertisers by identifying specific health-condition audiences across top health sites. Its ConditionMatchTM technology uses semantic analysis to find the most effective contextual pages for “diagnosed audiences” and continuously optimizes ad campaigns for performance. The company sells these audiences to pharma and consumer brands and operates from New York City. Precision Health Media raised an additional $1M in venture capital to support growth. The funding will be used to expand the sales team and further technology development. The company is led by CEO Bill Jennings and recently named Matthew Fink (formerly of Johnson & Johnson) as Vice President–Marketing.

Total raised

$1M

Funding rounds

1

Latest round

Equity

Latest activity

Mar 2012